全球家庭检测试剂盒市场 – 行业趋势及 2031 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

全球家庭检测试剂盒市场 – 行业趋势及 2031 年预测

  • Healthcare
  • Upcoming Report
  • Feb 2024
  • Global
  • 350 页面
  • 桌子數: 220
  • 图号: 60

全球家用检测试剂盒市场,按检测类型(妊娠检测、艾滋病毒检测试剂盒、糖尿病、传染病、葡萄糖检测、排卵预测检测试剂盒、药物滥用检测试剂盒、其他检测类型)、类型(盒式、试纸、中游、检测面板、浸卡、其他形式类型)、年龄(儿童、成人、老年人)、样本类型(尿液、血液、唾液、其他)、用途(一次性、可重复使用)、分销渠道(零售药店、药店、超市/大卖场、网上药店)划分 - 行业趋势和预测到 2031 年。

家庭检测试剂盒市场

家庭检测试剂盒市场分析及规模

家用检测试剂盒是一种检测仪器,可帮助人们在家中进行检测并在一分钟内快速获得结果。它还包括健康监测设备,用于持续检查和控制糖尿病患者的健康状况。家用检测非常方便,在家中即可舒适地进行,而且价格非常实惠。自我检测通常是快速即时检测试剂盒的高级版本,这种试剂盒最初是为医疗保健专业人员设计的,普通人也可以进行。

Data Bridge Market Research 分析,全球家用检测试剂盒市场规模在 2023 年为 74.4 亿美元,到 2031 年可能达到 119.5 亿美元,预计在预测期内的复合年增长率为 6.1%。由于人们对正确治疗的认识不断提高,“便携式设备”在市场分销渠道领域占据主导地位。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的洞察外,Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、渠道分析、定价分析和监管框架。

报告范围和市场细分

报告指标

细节

预测期

2024 至 2031 年

基准年

2023

历史岁月

2022 (可定制为 2016-2021)

定量单位

收入(单位:十亿美元)、销量(单位:台)、定价(美元)

涵盖的领域

按测试类型(妊娠测试、艾滋病毒测试套件、糖尿病、传染病、葡萄糖测试、排卵预测测试套件、药物滥用测试套件、其他测试类型)、类型(盒式、试纸、中段、测试面板、浸卡、其他表格类型)、年龄(儿童、成人、老年人)、样本类型(尿液、血液、唾液、其他)、用途(一次性、可重复使用)、分销渠道(零售药店、药店、超市/大卖场、网上药店)

覆盖国家

美国、加拿大、墨西哥、德国、意大利、英国、法国、西班牙、荷兰、比利时、瑞士、土耳其、俄罗斯、欧洲其他地区、日本、中国、印度、韩国、澳大利亚、新加坡、马来西亚、泰国、印度尼西亚、菲律宾、亚太其他地区、巴西、阿根廷、南美洲其他地区、南非、沙特阿拉伯、阿联酋、埃及、以色列、中东和非洲其他地区

涵盖的市场参与者

Abbott (U.S.), Siemens Healthcare GmbH (Germany), F. Hoffmann-La Roche Ltd (Switzerland), BD (Becton, Dickinson and Company) (U.S.), Drägerwerk AG & Co. KGaA (Germany) , LifeScan IP Holdings, LLC (U.S.), Ascensia Diabetes Care Holdings AG (Switzerland), Nectar Lifesciences Ltd. (Rapikit) (India), ACON Laboratories, Inc. (U.S.), Quidel Corporation (U.S.), ARKRAY USA, Inc. (U.S.), BTNX INC. (Canada), Atomo Diagnostics (Australia), Eurofins Scientific (Luxembourg), Piramal Enterprises Ltd. (India), Bionime Corporation (Taiwan), Nova Biomedical (U.S.), Cardinal Health (U.S.), OraSure Technologies (U.S.), Biolytical Laboratories Inc. (Canada), Everlywell, Inc. (U.S.), SA Scientific Ltd. (U.S.), Clearblue (a subsidiary of Swiss Precision Diagnostics GmbH) (U.K.), Biosynex (France), PRIMA Lab SA (Switzerland), MP BIOMEDICALS (U.S.), Sterilab Services (France), Chembio Diagnostics, Inc. (U.S.), BioSure (U.K.), Selfdiagnostics OU (Estonia)

Market Opportunities

  • Telehealth Integration
  • Technological Advancements

Market Definition

At-home testing kits, also known as home test kits or home diagnostic kits, are medical or health-related devices that allow individuals to perform specific tests or screenings for various conditions or diseases within the comfort of their own homes. These kits typically include necessary tools, instructions, and sometimes, prepaid packaging to send the collected samples back to a laboratory for analysis. At-home testing kits are designed to provide convenient and private ways for individuals to monitor their health, assess certain biomarkers, or detect specific health conditions without visiting a healthcare facility. These kits are commonly used for various purposes, such as pregnancy tests, blood glucose monitoring, DNA testing, sexually transmitted infection (STI) tests, and more.

Global At-Home Testing Kits Market Dynamics

Drivers

  • Growing Adoption of Self-Testing Kits

Earlier, people used to visit hospitals often, even for basic problems. However, as awareness has grown regarding several products, this behaviour has changed and has turned the trend. Nowadays, people prefer to get their basic tests done using test kits at home before visiting a doctor. This has become even more prominent due to this pandemic as people are adopting more self-help testing kits due to several restrictions in place. It has turned out to be a boon in disguise for both hospitals and patients as hospitals are already stretched thin and can entirely focus on COVID-19 patients, and the patients can save hefty costs of doctor visits and medicine fees. It has become highly convenient for consumers as they can quickly know their tests' results at their fingertips.

  • Testing Easy Availability of Self-Testing Kits at Pharmacies

At-home or self-testing kits are easily available at pharmacies, and it has become effortless to procure them. Various medical companies are venturing into this space as they rapidly manufacture self-test kits. This widespread availability can also be attributed to online pharmacies' medical start-ups, making availability easier by clicking a button. In addition, these self-testing kits are available without any prescription.

Opportunities

  • Telehealth Integration

The growing adoption of telehealth services presents an opportunity for at-home testing kits. Integrated telehealth platforms can streamline the process of obtaining test results, consultations, and further medical guidance.

  • Technological Advancements

Advances in technology, especially in the fields of diagnostics and biosensors, have led to the development of more accurate and user-friendly at-home testing kits. Improved accuracy, simplicity, and speed contribute to the market's growth.

Restraints/Challenges

  • Regulatory Challenges

Stringent regulatory requirements for the approval of at-home testing kits can pose a challenge for manufacturers. Navigating complex regulatory landscapes may slow down the introduction of new products to the market.

  • Limited Test Offerings

Some complex diagnostic tests may not be feasible for at-home use, limiting the scope of testing kits. Certain medical conditions may still require laboratory-based tests for accurate results.

Global At-Home Testing Kits Market Scope

The at-home testing kits market is segmented into six notable segments based on test type, type, age, sample type, usage, and distribution channels. The growth amongst these segments will help you analyze market growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Test Type

  • Pregnancy Test
  • HIV Test Kit
  • Diabetes
  • Infectious Diseases
  • Glucose Tests
  • Ovulation Predictor Test Kit
  • Drug Abuse Test Kit
  • Others

Type

  • Cassette
  • Strip
  • Midstream
  • Test Panel
  • Dip Card
  • Others

Age

  • Pediatric
  • Adult
  • Geriatric

Sample Type

  • Urine
  • Blood
  • Saliva
  • Others

 Usage

  • Disposable
  • Reusable

 Distribution Channels

  • Retail Pharmacies
  • Drug Store
  • Supermarket/Hypermarket
  • Online Pharmacies

 At-Home Testing Kits Market Regional Analysis/Insights

The at-home testing kits market is analyzed and market size insights and trends are provided based on test type, type, age, sample type, usage, and distribution channels as referenced above.

The countries covered in the market report are U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Netherlands, Switzerland, Russia, Turkey, Belgium, rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Indonesia, Thailand, Malaysia, Philippines, rest of Asia-Pacific, Brazil, Argentina, rest of South America, South Africa, Saudi Arabia, U.A.E, Israel, Egypt, and rest of Middle East and Africa.

由于北美地区的医疗保健支出较高且人们对家庭检测试剂盒市场的认识不断提高,预计北美将占据市场主导地位并呈现最快的增长速度。

报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和国内监管变化。下游和上游价值链分析、技术趋势和波特五力分析以及案例研究等数据点是用于预测各个国家市场情景的一些指标。此外,在对国家数据进行预测分析时,还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。     

医疗保健基础设施增长安装基础和新技术渗透

家用检测试剂盒市场还为您提供每个国家/地区资本设备医疗保健支出增长、家用检测试剂盒市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗保健监管情景的变化及其对家用检测试剂盒市场的影响的详细市场分析。数据适用于 2010-2020 年的历史时期。

竞争格局和家庭检测试剂盒市场份额分析

家用检测试剂盒市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对家用检测试剂盒市场的关注有关。

家庭检测试剂盒市场的一些主要参与者包括:

  • 雅培(美国)
  • 西门子医疗有限公司(德国)
  • F. Hoffmann-La Roche Ltd(瑞士)
  • BD (碧迪公司) (美国)
  • Drägerwerk AG & Co. KGaA(德国)
  • LifeScan IP Holdings, LLC(美国)
  • Ascensia Diabetes Care Holdings AG(瑞士)
  • Nectar Lifesciences Ltd. (Rapikit)(印度)
  • ACON Laboratories, Inc.(美国)
  • Quidel Corporation(美国)
  • ARKRAY USA, Inc.(美国)
  • BTNX INC.(加拿大)
  • Atomo Diagnostics(澳大利亚)
  • Eurofins Scientific(卢森堡)
  • 皮拉马尔企业有限公司 (印度)
  • 生化科技股份有限公司 (台湾)
  • Nova Biomedical(美国)
  • 康德乐 (美国)
  • OraSure Technologies(美国)
  • Biolytical Laboratories Inc.(加拿大)
  • Everlywell, Inc.(美国)
  • SA Scientific Ltd.(美国)
  • Clearblue(Swiss Precision Diagnostics GmbH 的子公司)(英国)
  • Biosynex(法国)
  • PRIMA Lab SA(瑞士)
  • MP BIOMEDICALS(美国)
  • Sterilab Services(法国)
  • Chembio Diagnostics, Inc.(美国)
  • BioSure(英国)
  • Selfdiagnostics OU(爱沙尼亚)


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The At-Home Testing Kits Market size will be worth USD 11.95 billion by 2031 during the forecast period.
The At-Home Testing Kits Market growth rate is 6.1% during the forecast period.
The Testing Easy Availability of Self-Testing Kits at Pharmacies and Growing Adoption of Self-Testing Kits are the growth drivers of the At-Home Testing Kits Market.
The test type, type, age, sample type, usage, and distribution channels are the factors on which the At-Home Testing Kits Market research is based.
The major companies in the At-Home Testing Kits Market are Abbott (U.S.), Siemens Healthcare GmbH (Germany), F. Hoffmann-La Roche Ltd (Switzerland), BD (Becton, Dickinson and Company) (U.S.), Drägerwerk AG & Co. KGaA (Germany) , LifeScan IP Holdings, LLC (U.S.), Ascensia Diabetes Care Holdings AG (Switzerland), Nectar Lifesciences Ltd. (Rapikit) (India), ACON Laboratories, Inc. (U.S.), Quidel Corporation (U.S.), ARKRAY USA, Inc. (U.S.), BTNX INC. (Canada), Atomo Diagnostics (Australia), Eurofins Scientific (Luxembourg), Piramal Enterprises Ltd. (India), Bionime Corporation (Taiwan), Nova Biomedical (U.S.), Cardinal Health (U.S.), OraSure Technologies (U.S.), Biolytical Laboratories Inc. (Canada), Everlywell, Inc. (U.S.), SA Scientific Ltd. (U.S.), Clearblue (a subsidiary of Swiss Precision Diagnostics GmbH) (U.K.), Biosynex (France), PRIMA Lab SA (Switzerland), MP BIOMEDICALS (U.S.), Sterilab Services (France), Chembio Diagnostics, Inc. (U.S.), BioSure (U.K.), Selfdiagnostics OU (Estonia).